A Legacy of Innovation
To change how difficult diseases are treated, we must keep our eyes locked on the possibilities ahead. But it’s equally important to occasionally look back, to contextualize successes and learn from mistakes; to examine the efforts that turned the unthinkable into reality.
Join us in exploring the foundational stories of our work – not just the scientific achievements, but all the accompanying innovations that happened along the way.
Rebels in Cancer Research
AbbVie researchers Andrew Petros and Phil Hajduk are rebels, but you might not know it to look at them.
Cancer cells differ from healthy cells in several ways; key among them is their ability to avoid death. This resistance to death was a well-known hallmark of cancer cells. However, Petros and Hajduk had an idea.
As researchers who spent their careers – 29 years and 19 years, respectively – developing medicines at AbbVie, they were trained to follow the rules and principles of science: ideas that are known to be true, until someone finds a way to prove them wrong.